Pharmaceutical Company: Migrating Content From a Legacy System to OpenText Documentum for Life Sciences R&D With Limited Metadata

Challenge

A global generic and specialty pharmaceutical company had the challenge to migrate all their submission-based data from their current OpenText Documentum D2 application to the new OpenText Documentum for Life Sciences R&D solution. The source system support contract was reaching its expiration date and had limited capabilities and functionalities compared to the Research and Development solution.

Client

Global Pharmaceutical Company

Technologies:

»fme has been a trusted partner for migration for many years. The migration to OpenText Documentum for Life Sciences Research and Development solution posed many challenges and the enrichment of our data was critical. With the use of fme services and migration-center, we achieved a successful project and a unified R&D platform.«

Project Manager

Global Pharmaceutical Company

Case Study | Pharmaceutical Company: Migrating Content From a Legacy System to OpenText Documentum for Life Sciences R&D With Limited Metadata

Contact

Please contact us

1 Step 1
Salutation
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right

Laurissa Primavera

Director of Sales fme US, LLC